Physician profile
Michael Drew Honaker
NPI 1700010394
$1,265.09
in general payments reported to CMS, 2019-2025
11 companies · $84.18 in 2025
The $84.18 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $921 · 2020: $223 · 2021: $24.71 · 2022: $12.86 · 2025: $84.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $84.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $84.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $856.98 | 2019 | |
| Axonics, INC. | $133.06 | 2020-2022 | |
| Biom'Up France Sas | $52.15 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.26 | 2025 | Entyvio |
| Allergan, INC. | $41.86 | 2020-2021 | |
| Olympus America INC. | $38.92 | 2025 | Visiglide |
| Acell, INC. | $25.00 | 2019 | |
| Medtronic USA, INC. | $20.46 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $19.97 | 2019 | |
| Thd America, INC. | $19.40 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $12.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Honaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.